Postirradiation morphea of the breast. Presentation of two cases and review of the literature

Dermatology

Volumn 200, Issue 1, 2000, Pages 67-71

  Schaffer, Julie V ^a   Carroll, Carolyn ^a   Dvoretsky, Israel ^a   Huether, Michael J ^a   Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; Fibrosis; Morphea; Radiation therapy; Supervoltage

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; MORPHEA; PRIORITY JOURNAL; RADIATION INJURY; SCLEROSIS;

EID: 0033950302     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018322     Document Type: Article

References (22)

1. Dering SB: Modern Radiology in Histological Perspective. Springfield, Thomas, 1960, p 105.
2. Varga J, Haustein UF, Creech RH, Dwyer JP, Jimenez SA: Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 1990;265:3293-3295.
3. Liegner LM, Michaud NJ: Skin and subcutaneous reactions induced by supervoltage irradiation. Am J Roentgenol 1961;85:533-549.
4. Davis DA, Cohen PR, McNeese MD, Duvic M: Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: Radiation port scleroderma. J Am Acad Dermatol 1996;35:923-927.
5. Winkelmann RK, Graso GL, Quimby SR, Connolly SM: Pseudoscleromatous panniculitis after irradiation: An unusual complication of megavoltage treatment of breast cancer. Mayo Clin Proc 1993;68:122-127.
6. Trattner A, Figer A, David M, Lurie H, Sandbank M: Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 1991;68:2131-2133.
7. Colver GB, Rodger A, Mortimer PS, Savin JA, Neill SM, Hunter JAA: Post-irradiation morphea. BrJ Dermatol 1989;120:831-835.
8. Forbes AM, Woodrow JC, Verbov JL, Groham RM: Carcinoma of the breast and scleroderma: Four further cases and a literature review. Br J Rheumatol 1989;29:65-69.
9. Smith KJ, Yeager J, Skelton HG: Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: Radiation port scleroderma (letter, comment). J Am Acad Dermatol 1997;37:806-807.
10. Gollob MH, Dekoven JG, Bell MJ, Assaad D, Rao J: Postradiation morphea. J Rheumatol 1998;25:2267-2269.
11. Clarke D, Martinez A, Cox RD: Analysis of cosmetic results and complications in patients with Stage I and II breast cancer treated by biopsy and irradiation. Int J Radiat Oncol Biol Phys 1983;9:533-549.
12. Bentzen SM, Thames HD, Overgaard M: Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single follow-up clinical study. Radiother Oncol 1989; 15:267-274.
13. Archambeau JO, Pezner R, Wasserman T: Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995;31:1171-1185.
14. James WD, Odom RB: Late subcutaneous fibrosis following megavoltage radiotherapy. J Am Acad Dermatol 1980;3:616-618.
15. Harrison GO, Elliott RL: Scleroderma of the breast: Light and electron microscopy study. Am Surg 1987;9:528-531.
16. Peterson LS, Nelson AM, Su WPD, Mason T, O'Fallon WM, Gabriel SE: The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
17. Greenberg GS, Falanga V: Localized cutaneous sclerosis; in Sontheimer RD, Provost TT (eds): Cutaneous Manifestations of Rheumatic Diseases. Baltimore, Williams & Wilkins, 1996, pp 141-155.
18. Lee EB, Anhalt GJ, Voorhees JJ, Diaz LA: Pathogenesis of scleroderma: Current concepts. Int J Dermatol 1984;23:85-89.
19. Charley MR, Deng JS: Murine models of graft-versus-host disease with features of scleroderma. Immunol Ser 1989;46:625-640.
20. Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-1191.
21. Smith EA, LeRoy EC: A possible role for transforming growth factor in systemic sclerosis. J Invest Dermatol 1990;95:1255-1275.
22. Kikuchi K, Kadono T, Ihn H, Sato S, Igarashi A, Nakagawa H, Tamaki K, Takehara K: Growth regulation in scleroderma fibroblasts: Increased response to transforming growth factor-beta 1. J Invest Dermatol 1995;105:128-132.